Cytotoxicity Study – ISO Direct Contact Method

The cytotoxicity ISO direct contact method evaluates the potential toxicity of medical devices when they come into direct contact with living cells. This test assesses whether the materials used in the device cause any adverse effects on cell viability, proliferation, or morphology. Ensuring that medical devices are non-toxic is crucial for patient safety and biocompatibility.  This method is appropriate for devices or materials that can be placed directly on the cell monolayer surface, such as a contact lens.

Why This Assessment is Performed

Cytotoxicity testing is performed to ensure that medical devices do not harm living cells, which is essential for patient safety. This testing helps identify any toxic effects that materials might have on cells, ensuring that the device is safe for use in medical applications.

Have you tried our Test Navigator Tool? Try it now

Steps in Conducting This Test

1. Sample Preparation: Prepare samples of the medical device material for testing.
2. Cell Culture: Culture appropriate cell lines, such as fibroblasts or epithelial cells, in a controlled environment.
3. Direct Contact: Place the device material in direct contact with the cultured cells.
4. Incubation: Incubate the cells with the device material for a specified period, typically 24 hours.
5. Evaluation: Assess cell viability, proliferation, and morphology using microscopic examination.
6. Interpretation: Assign a grade of cytotoxicity based on the severity of the response (Grades 0-4) as stated in ISO 10993-5.

Standards, Guidance, and Regulations

When conducting cytotoxicity testing for medical devices, it is essential to follow specific standards and guidelines:

• ISO 10993-5: This international standard provides guidelines for in vitro cytotoxicity testing of medical devices.
• FDA Guidance: The U.S. Food and Drug Administration (FDA) provides specific guidance on conducting cytotoxicity testing for medical devices within the FDA Guidance to Industry – Use of International Standard ISO 10993-1, “Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process”.